In PlGF/RGS4 mice, the angiogenesis-induced hypertrophic response was completely prevented compared with PlGF mice and the extent of myocardial hypertrophy and the decline in cardiac function after TAC were each comparable with control (Fig. 5b–d). This evidence concerns the gene RGS4 and cardiac hypertrophy.